BioSpectrum Asia - November 2023

في هذه القضية

Addressing Diabetes-related complications
Southeast Asia is currently home to 90 million adults diagnosed with diabetes, and this number is expected to reach 113 million by 2030, according to the International Diabetes Federation (IDF) Diabetes Atlas 2022. Out of these 90 million, 46 million remain undiagnosed. The delayed diagnosis of diabetes leads to prolonged periods of uncontrolled hyperglycemia, resulting in severe diabetes related complications, such as diabetic retinopathy (eye problems), diabetic foot ulcers (DFU), diabetic nephropathy (kidney problems), and cardiovascular diseases. The vast number of people affected by diabetes, including many who are undiagnosed or at risk, presents a massive market for innovative treatments and preventive solutions. New technologies and novel treatment approaches offer hope for better prevention and management of these diabetes-related complications.

Addressing Diabetes-related Complications

Southeast Asia is currently home to 90 million adults diagnosed with diabetes, and this number is expected to reach 113 million by 2030, according to the International Diabetes Federation (IDF) Diabetes Atlas 2022. Out of these 90 million, 46 million remain undiagnosed.

10+ mins

Prediabetes can significantly impact quality of life

Even though prediabetes is a leading risk factor for diabetes and may predict cardiovascular disease and increased mortality, the degree of unawareness is very high with up to 85 per cent not being aware of their condition. Early diagnoses can help enable better treatment outcomes, better quality of life, and damaged nerves can be regenerated if nerve care damage has not progressed too far.

3 mins

"Computer-Aided Diagnosis provided by Al needs to gain trust from doctors"

In November 2022, The Industrial Technology Research Institute (ITRI), Taiwan’s prominent high-tech research institution, launched Point-of Care AI-DR, the first AI-assisted system integrated into commonly used handheld and desktop fundus cameras in healthcare settings for diabetic retinopathy (DR) and diabetic macular edema (DME) detection. Dr Lee Ya-wen, Technical Manager, ICL, ITRI sheds more light on ITRI’s Point-of-Care AI-DR system, opportunities and challenges of AI-assisted diagnostic systems etc. Edited excerpts:

4 mins

Disruptive Technologies and New Industry Initiatives for Diabetes Management

Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regions. Large players are very intent on tapping the large market potential in Asia. Many global companies have set up local presence in Asian countries and local production through OEM partners in the countries to bring down the cost of their solutions, and more companies are expected to follow.

10 mins

Pushing The Age Barrier

In 2022, 1 in 7 individuals in Asia Pacific were aged 60 or older. This demographic trend is accelerating, with projections suggesting that by 2050, 1 in 4 people in the region will fall into this age group, according to the United Nations, Economic and Social Commission for Asia and the Pacific (ESCAP), 2022.

5 mins

The Changing Face of Chromatography

From cutting-edge gene therapies to groundbreaking MRNA vaccines, innovative approaches hold tremendous promise for treating and preventing diseases. However, their development and production pose unique challenges that demand equally innovative solutions. Let’s look at how chromatography, a foundational technique in biopharmaceutical manufacturing, is keeping pace with these new therapies and explore the latest developments in the chromatography market.

4 mins

"Continuous innovation and adherence to global quality will be key to maintaining India's growth in pharma exports"

The Indian Pharmaceutical Industry is celebrating an unprecedented milestone, with exports reaching a staggering $25.3 billion by the end of the first quarter of the 2023 fiscal year.

4 mins

"Across AMEA, the biopharma industry is seeing a greater emphasis on local production and supply chain resilience"

Avantor, the leading global provider of life sciences and advanced technology solutions, inaugurated Singapore Manufacturing & Distributing Hub (SMDH) mid this year.

8 mins

"NEOM is fundamentally reshaping health by placing a strong emphasis on personalised care"

The core of a holistic health reform lies in the integration of emerging cuttingedge technologies into personalised care, emphasising interdisciplinary approaches.

5 mins

30 Young CEOs Closely Contest the Best Bio CEO Awards

The race was on among young biotech CEOs for top position in 2023 Best Bio CEO awards organised by Global Bio and Investment media in Taipei, Taiwan.

3 mins

قراءة كل الأخبار من BioSpectrum Asia

BioSpectrum Asia Magazine Description:

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.